Methods and compositions for treating glioblastoma
AssigneeNeoTX Therapeutics Ltd.
InventorsMichal Shahar, Asher Nathan
Life of this patent
Estimating the term…
Abstract
The disclosure provides methods and compositions for treating glioblastoma (GBM) using a 5T4-targeting agent, e.g., a superantigen conjugate comprising an anti-5T4 antibody.
Claims24
A method of reducing tumor volume in a subject with glioblastoma, the method comprising administering to the subject an effective amount of a 5T4-targeting agent.
A method of killing tumor cells in a subject with glioblastoma, the method comprising administering to the subject an effective amount of a 5T4-targeting agent.
A method of treating glioblastoma in a subject in need thereof, the method comprising administering to the subject an effective amount of a 5T4-targeting agent.
Dependencies are inferred from the claim text.